Automated parallel solid-phase synthesis of non-peptide CCR1 receptor antagonists.
An automated, parallel, solid-phase synthesis and screening strategy using commercially available aryl acetic acids as starting materials has discovered novel, non-peptide CCR1 antagonists (K(i) < 100 nM).